{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:51:47Z","timestamp":1792889507757,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jfo.2013.07.004","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T03:45:13Z","timestamp":1384487113000},"page":"874-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prise en charge diagnostique et th\u00e9rapeutique d\u2019une orbitopathie dysthyro\u00efdienne\u00a0: une affection multidisciplinaire"],"prefix":"10.1016","volume":"36","author":[{"given":"B.","family":"Leray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Thouvenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Boutault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2013.07.004_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9394(14)72666-2","article-title":"The incidence of Graves\u2019 ophthalmopathy in Olmsted County, Minnesota","volume":"120","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjmed.2009.06.030","article-title":"Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease","volume":"123","author":"Boelaert","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.jfo.2013.07.004_bib0015","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0140-6736(91)92298-G","article-title":"Stressful life events and Graves\u2019 disease","volume":"338","author":"Winsa","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2013.07.004_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0140-6736(91)90013-F","article-title":"Thyroid-associated eye disease: pathophysiology","volume":"338","author":"Weetman","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2013.07.004_bib0025","first-page":"1194","article-title":"Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy","volume":"85","author":"Hiromatsu","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2013.07.004_bib0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2265.1999.00681.x","article-title":"Octreotide-scintigraphy is a disease-activity parameter in Graves\u2019 ophthalmopathy","volume":"50","author":"Gerding","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jfo.2013.07.004_bib0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1530\/eje.0.1360599","article-title":"Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue","volume":"136","author":"Spitzweg","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/105072501300042929","article-title":"Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy","volume":"11","author":"Marin\u00f2","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.jfo.2013.07.004_bib0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/thy.1992.2.299","article-title":"Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy","volume":"2","author":"Hiromatsu","year":"1992","journal-title":"Thyroid"},{"key":"10.1016\/j.jfo.2013.07.004_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jfo.2013.07.004_bib0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/eje.1.02230","article-title":"Clinical assessment of patients with Graves\u2019 orbitopathy: the European Group on Graves\u2019 Orbitopathy: recommendations to generalists, specialists and clinical researchers","volume":"155","author":"Wiersinga","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9394(77)90140-4","article-title":"Modification of the classification of the eye changes of Graves\u2019 disease","volume":"83","author":"Werner","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy","volume":"18","author":"Bartalena","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.jfo.2013.07.004_bib0070","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archinte.1990.00390170124027","article-title":"Effect of abnormal thyroid function on the severity of Graves\u2019 ophthalmopathy","volume":"150","author":"Prummel","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfo.2013.07.004_bib0075","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/thy.2005.15.1157","article-title":"Graves\u2019 disease with moderate-severe endocrine ophthalmopathy: long-term results of a prospective, randomized study of total or subtotal thyroid resection","volume":"15","author":"J\u00e4rhult","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.jfo.2013.07.004_bib0080","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism. The Thyroid Study Group","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2013.07.004_bib0085","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1530\/eje.0.1300494","article-title":"Does early administration of thyroxine reduce the development of Graves\u2019 ophthalmopathy after radioiodine treatment?","volume":"130","author":"Tallstedt","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves\u2019 ophthalmopathy","volume":"338","author":"Bartalena","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2013.07.004_bib0095","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2005-0507","article-title":"A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves\u2019 ophthalmopathy","volume":"90","author":"Perros","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2013.07.004_bib0100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-129-8-199810150-00010","article-title":"Cigarette smoking and treatment outcomes in Graves\u2019 ophthalmopathy","volume":"129","author":"Bartalena","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfo.2013.07.004_bib0105","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves\u2019 orbitopathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2013.07.004_bib0110","first-page":"168","article-title":"Management of Graves\u2019 ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jfo.2013.07.004_bib0115","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves\u2019 orbitopathy","volume":"90","author":"Kahaly","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2013.07.004_bib0120","first-page":"120","article-title":"Graves\u2019 orbitopathy: a multidisciplinary approach","author":"Wiersinga","year":"2007","journal-title":"Karger"},{"key":"10.1016\/j.jfo.2013.07.004_bib0125","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","article-title":"Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves\u2019 orbitopathy","volume":"97","author":"Bartalena","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2013.07.004_bib0130","first-page":"3562","article-title":"Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves\u2019 ophthalmopathy: results of a prospective, single-blind, randomized study","volume":"86","author":"Marcocci","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2013.07.004_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.1987.tb00836.x","article-title":"Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves\u2019 ophthalmopathy: a comparative study","volume":"27","author":"Marcocci","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jfo.2013.07.004_bib0140","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1210\/jc.2012-2758","article-title":"Efficacy and safety of orbital radiotherapy for Graves\u2019 orbitopathy","volume":"97","author":"Tanda","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2013.07.004_bib0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijrobp.2010.08.053","article-title":"The efficacy of radiation therapy in the treatment of Graves\u2019 orbitopathy","volume":"82","author":"Matthiesen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jfo.2013.07.004_bib0150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jcem-56-6-1139","article-title":"Orbital cobalt irradiation combined with systemic corticosteroids for Graves\u2019 ophthalmopathy: comparison with systemic corticosteroids alone","volume":"56","author":"Bartalena","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2013.07.004_bib0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0029-1211086","article-title":"Glucocorticoid therapy of Graves\u2019 ophthalmopathy","volume":"97","author":"Bartalena","year":"1991","journal-title":"Exp Clin Endocrinol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2362.1986.tb01016.x","article-title":"Ciclosporin and prednisone v. prednisone in treatment of Graves\u2019 ophthalmopathy: a controlled, randomized and prospective study","volume":"16","author":"Kahaly","year":"1986","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jfo.2013.07.004_bib0165","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198911163212002","article-title":"Prednisone and cyclosporine in the treatment of severe Graves\u2019 ophthalmopathy","volume":"321","author":"Prummel","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2013.07.004_bib0170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/thy.1998.8.443","article-title":"Somatostatin analogues in the treatment of thyroid eye disease","volume":"8","author":"Krassas","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.jfo.2013.07.004_bib0175","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2004-1334","article-title":"Octreotide (long-acting release formulation) treatment in patients with Graves\u2019 orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study","volume":"90","author":"W\u00e9meau","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2013.07.004_bib0180","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clim.2008.12.005","article-title":"Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates","volume":"131","author":"Salvi","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0185","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00006534-199104000-00004","article-title":"Transpalpebral decompression of endocrine ophthalmopathy (Graves\u2019 disease) by removal of intraorbital fat: experience with 147\u00a0operations over 5years","volume":"87","author":"Olivari","year":"1991","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jfo.2013.07.004_bib0190","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00006534-198911000-00006","article-title":"Surgical treatment of thyrotoxic exophthalmos","volume":"84","author":"Roncevic","year":"1989","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jfo.2013.07.004_bib0195","first-page":"31","article-title":"Basedow exophthalmos: lipectomy or orbital expansion?","volume":"40","author":"Gola","year":"1995","journal-title":"Ann Chir Plast Esthet"},{"key":"10.1016\/j.jfo.2013.07.004_bib0200","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/112067219800800408","article-title":"Treatment of proptosis with fat removal orbital decompression in Graves\u2019 ophthalmopathy","volume":"8","author":"Adenis","year":"1998","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0205","first-page":"56","article-title":"Transantral orbital decompression for malignant exophthalmos","volume":"59","author":"Walsh","year":"1957","journal-title":"Trans Am Laryngol Rhinol Otol Soc"},{"key":"10.1016\/j.jfo.2013.07.004_bib0210","first-page":"288","article-title":"Transconjunctival surgery","volume":"23","author":"Silkiss","year":"1992","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.jfo.2013.07.004_bib0215","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bjo.84.7.775","article-title":"Transconjunctival orbital decompression in Graves\u2019 ophthalmopathy: lateral wall approach ab interno","volume":"84","author":"Paridaens","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.IOP.0000056145.71641.F5","article-title":"Balanced orbital decompression combined with fat removal in Graves ophthalmopathy: do we really need to remove the third wall?","volume":"19","author":"Unal","year":"2003","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.jfo.2013.07.004_bib0225","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.clinbiomech.2005.05.017","article-title":"Computer assisted planning and orbital surgery: patient-related prediction of osteotomy size in proptosis reduction","volume":"20","author":"Luboz","year":"2005","journal-title":"Clin Biomech"},{"key":"10.1016\/j.jfo.2013.07.004_bib0230","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.IOP.0000161714.45366.36","article-title":"Incidence of infraorbital hypesthesia and sinusitis after orbital decompression for thyroid-related orbitopathy: a comparison of surgical techniques","volume":"21","author":"Carrasco","year":"2005","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.jfo.2013.07.004_bib0235","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1100\/2012\/312361","article-title":"Transcaruncular medial wall orbital decompression: an effective approach for patients with unilateral Graves\u2019 ophthalmopathy","volume":"2012","author":"Hill","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jfo.2013.07.004_bib0240","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.IOP.0000092796.43025.B1","article-title":"Orbital decompression: a comparison between trans-fornix\/transcaruncular inferomedial and coronal inferomedial plus lateral approaches","volume":"19","author":"Cruz","year":"2003","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.jfo.2013.07.004_bib0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0161-6420(81)34995-1","article-title":"Orbital decompression for Graves\u2019 disease. Exposure through lateral canthal and inferior fornix incision","volume":"88","author":"McCord","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2013.07.004_bib0250","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/IOP.0b013e31824dd8a0","article-title":"Cosmetic orbital inferomedial decompression: quantifying the risk of diplopia associated with extraocular muscle dimensions","volume":"28","author":"Eing","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.jfo.2013.07.004_bib0255","first-page":"487","article-title":"Les troubles oculomoteurs dans les orbitopathies dysthyro\u00efdienne","volume":"10","author":"Morax","year":"1996","journal-title":"Ophtalmologie"},{"key":"10.1016\/j.jfo.2013.07.004_bib0260","series-title":"Les troubles oculomoteurs de l\u2019orbitopathie endocrinienne. La chirurgie oculomotrice","first-page":"364","author":"Roth","year":"1995"},{"key":"10.1016\/j.jfo.2013.07.004_bib0265","series-title":"Strabologie\u00a0: approches diagnostique et th\u00e9rapeutique","first-page":"173","article-title":"Maladie de Basedow et atteinte oculomotrice","author":"Pelosse","year":"2008"},{"key":"10.1016\/j.jfo.2013.07.004_bib0270","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0181-5512(07)89609-4","article-title":"Surgical management of diplopia in dysthyroid orbitopathy","volume":"30","author":"Bok","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/bjo.78.3.167","article-title":"Adjustable sutures in eyelid surgery for ptosis and lid retraction","volume":"78","author":"Collin","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.07.004_bib0280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00002341-200405000-00001","article-title":"Botulinum toxin type a for dysthyroid upper eyelid retraction","volume":"20","author":"Morgenstern","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551213003288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551213003288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:04:21Z","timestamp":1759259061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551213003288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0181551213003288"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2013.07.004","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge diagnostique et th\u00e9rapeutique d\u2019une orbitopathie dysthyro\u00efdienne\u00a0: une affection multidisciplinaire","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2013.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}